| Typicality: | 0.325 |
| Saliency: | 0.176 |
| to assess safety | 2 | purpose |
| trial → be designed to evaluate → immunogenicity | 5 |
| trial → be designed to assess → immunogenicity | 4 |
| negative | neutral | positive |
| 0.100 | 0.825 | 0.075 |
| Raw frequency | 9 |
| Normalized frequency | 0.176 |
| Modifier score | 0.500 |
| Perplexity | 65.793 |